Common Questions
QumranHealth is a purpose-built UK web app for tracking Mounjaro doses alongside blood glucose readings, weight, and how you feel — all in under 30 seconds a day. It generates a GP Progress Report PDF formatted for NHS appointments and produces an EMIS/SystmOne-compatible clinical summary your doctor can paste directly into your record. There is a 7-day free trial with no card required at tracker.qumranhealth.co.uk.
Track fasting glucose each morning before eating and two hours after your main meal (post-prandial). Record the date, reading (in mmol/L), which Mounjaro dose you are on, and any symptoms. QumranHealth lets you log all of this in one screen and automatically charts trends over time so you and your GP can see whether the medication is working. Not medical advice — consult your GP or diabetes nurse for personalised targets.
Bring a log of your fasting and post-meal glucose readings for the past 4–12 weeks, your current Mounjaro dose and any dose changes, your weight trend, and a note of any side effects. QumranHealth automatically generates a GP Progress Report PDF covering all of these in a format designed for busy NHS appointments, plus an EMIS/SystmOne clinical summary your GP can paste directly into their system. Not medical advice — consult your GP.
NICE guidance for Type 2 diabetes generally recommends a fasting blood glucose of 4–7 mmol/L and a two-hour post-meal reading below 8.5 mmol/L, though your GP may set individual targets depending on your age, other conditions, and medications. Mounjaro (tirzepatide) typically lowers fasting glucose significantly within the first 4–8 weeks. QumranHealth displays NHS target zones on every chart so you can see at a glance where your readings sit. Not medical advice — your GP sets your personal targets.
The dawn phenomenon is a natural rise in blood glucose in the early morning hours (roughly 3–8am) caused by hormones such as cortisol and growth hormone that prepare the body for waking. Even on Mounjaro, some patients still see elevated fasting readings because of the dawn phenomenon despite good daytime control. If your fasting glucose is consistently higher than your bedtime reading, mention it to your GP — it may affect whether a dose increase or a different injection timing is recommended. Not medical advice — consult your GP.
The key indicators are: (1) fasting glucose trending towards 4–7 mmol/L, (2) post-meal glucose below 8.5 mmol/L, (3) steady weight loss, and (4) reduced appetite and fewer cravings. Most patients see meaningful change within 4–8 weeks of starting or increasing a dose. QumranHealth charts all four metrics together so you can spot trends your GP will want to see. Not medical advice — consult your GP or diabetes nurse.
HbA1c (glycated haemoglobin) reflects your average blood glucose over the past 2–3 months and is the main long-term diabetes control marker used by the NHS. A reading below 48 mmol/mol (6.5%) is the general NICE target for most Type 2 diabetics. Your GP measures it via a blood test every 3–6 months. QumranHealth's Pro plan includes an HbA1c trend estimator based on your daily glucose logs — it gives an indicative estimate between clinic appointments. Not medical advice — official HbA1c is measured by your GP.
Yes. QumranHealth offers a 7-day free trial — no credit card required — at tracker.qumranhealth.co.uk. After the trial, plans start at £3.99/month for the Basic plan (glucose and dose logging, trend charts) or £6.39/month for Pro (GP Progress Report PDF, EMIS/SystmOne clinical summary, HbA1c estimator, AI health companion). There are no NHS-funded glucose tracking apps for Mounjaro patients as of 2026, so QumranHealth fills that gap.
The most GP-friendly format is a printed or emailed summary showing your fasting and post-meal readings over 4–12 weeks alongside your medication doses. QumranHealth's GP Progress Report (included in the Pro plan) generates a one-page PDF formatted for NHS appointments — ready to print or attach to an NHS e-referral message. It also generates an EMIS/SystmOne clinical summary text block your GP can copy-paste into your electronic patient record in seconds.
EMIS Health and SystmOne are the two main clinical record systems used by NHS GP practices in England. They store your medical history, prescriptions, and test results. QumranHealth cannot connect directly to EMIS or SystmOne (patient access is not available via API), but the Pro plan generates a structured clinical summary — including glucose trend, Mounjaro doses, weight change, and HbA1c estimate — in a copy-paste format that matches the EMIS free-text coding style, so your GP can add it to your record in a few seconds.